Indianapolis, IN, United States of America

Bryan Hurst Norman

USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 107(Granted Patents)


Location History:

  • Indiannapolis, IN (US) (2004)
  • Indianapolis, IN (US) (1997 - 2017)

Company Filing History:


Years Active: 1997-2017

Loading Chart...
Loading Chart...
31 patents (USPTO):

Title: Bryan Hurst Norman: A Pioneer in Autotaxin Inhibitors

Introduction

Bryan Hurst Norman, based in Indianapolis, IN, is a prominent inventor with an impressive portfolio, holding a total of 31 patents. His contributions to the field of pharmaceuticals, particularly in the development of autotaxin inhibitors, are notable and have significant implications for the treatment of pain associated with conditions such as osteoarthritis.

Latest Patents

Among his latest innovations, Norman has developed compounds like dihydropyrido pyrimidine compounds, which serve as autotaxin inhibitors. These compounds are beneficial in alleviating pain linked to osteoarthritis. Another significant patent involves imidazo pyridine compounds, which also function as autotaxin inhibitors. These breakthroughs continue to push the boundaries of medical science and improve patient outcomes.

Career Highlights

Throughout his career, Bryan Hurst Norman has made substantial contributions to leading companies in the pharmaceutical sector. He has worked with Eli Lilly and Company, where he likely enhanced his expertise in drug development and research. Additionally, his tenure at G.D. Searle & Company further solidified his reputation within the industry, allowing him to focus on innovative therapeutic strategies.

Collaborations

Norman has collaborated with esteemed colleagues, including James A. Sikorski and Balekudru Devadas. These partnerships have undoubtedly enriched his research endeavors and led to impactful advancements in the field.

Conclusion

Bryan Hurst Norman's innovative spirit and dedication to research exemplify the essence of a successful inventor. His work in autotaxin inhibitors not only marks significant progress in pharmaceuticals but also showcases the importance of collaboration in driving scientific advancements. As he continues to push the boundaries of innovation, Norman remains a key figure in the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…